about
Reawakening retrocyclins: ancestral human defensins active against HIV-1Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infectionsContext mediates antimicrobial efficacy of kinocidin congener peptide RP-1A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusionGrifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, GriffithsinOxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipidsLateral stress relaxation and collapse in lipid monolayersCyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.Critical structural and functional roles for the N-terminal insertion sequence in surfactant protein B analogs.Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR.Functional importance of the NH2-terminal insertion sequence of lung surfactant protein B.The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaquesStructures of β-hairpin antimicrobial protegrin peptides in lipopolysaccharide membranes: mechanism of gram selectivity obtained from solid-state nuclear magnetic resonance.Novel dimeric Smac analogs as prospective anticancer agents.Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overloadKL₄ peptide induces reversible collapse structures on multiple length scales in model lung surfactantBridged Analogues for p53-Dependent Cancer Therapy Obtained by S-AlkylationUncovering the Mechanism of Aggregation of Human Transthyretin.Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.G418-mediated ribosomal read-through of a nonsense mutation causing autosomal recessive proximal renal tubular acidosis.Roles of arginine and lysine residues in the translocation of a cell-penetrating peptide from (13)C, (31)P, and (19)F solid-state NMR.A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.Inhibitors of HIV-1 entry.The pathophysiology and pharmacology of hepcidin.Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron.alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s).4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues.Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus.Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.Surfactant protein C peptides with salt-bridges ("ion-locks") promote high surfactant activities by mimicking the α-helix and membrane topography of the native proteinThiol-derivatized minihepcidins retain biological activity.Small cyclic agonists of iron regulatory hormone hepcidin.Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells.Mitochondrial dysfunction, through impaired autophagy, leads to endoplasmic reticulum stress, deregulated lipid metabolism, and pancreatitis in animal models.Conformation and Trimer Association of the Transmembrane Domain of the Parainfluenza Virus Fusion Protein in Lipid Bilayers from Solid-State NMR: Insights into the Sequence Determinants of Trimer Structure and Fusion Activity.Identification of novel small-molecule inhibitors of Zika virus infection.Quantitative Measure of Intestinal Permeability Using Blue Food ColoringInsights into the structure and molecular topography of the fatty acylated domain of synaptotagmin-1The Aftermath of Surviving Acute Radiation Hematopoietic Syndrome and its Mitigation
P50
Q21145822-2BB79EFC-CB97-499B-9A3A-5E80B4D3DE71Q24607197-33BD68AC-34EA-4C5A-AAC4-F9AD824C2C1BQ28477816-269461BE-BEDE-4355-B5B7-0D77DF517B91Q28485957-1E792609-4A12-466F-951A-4E1E037EC92EQ28744163-ABAEB307-E445-4272-B262-323256489B69Q28752575-1BAE1448-DF2A-4245-B2F6-155C1E923DBFQ30489266-2B652DEA-4651-45E1-A922-04A1755A6958Q33200404-85926730-7F42-4880-9A9A-C51D5EBCE47EQ33525036-A827589D-7994-45E5-8A4D-ACAF00CE8288Q33605186-90A7EAD1-7560-4D61-BF16-C2A355D520F9Q33728231-0B13FCD9-56F7-490D-988A-16C9CA5A9816Q33760642-8D7C8B8F-39B4-45C5-B241-C9A89163258AQ34709011-E92D52E8-989D-48DB-AE94-18201E8AC58EQ35105107-450D2668-716B-44C3-9FCD-C960D3327E7AQ35578602-58C6F179-BAA7-4D49-B522-AABABEEF239AQ35627754-4295CE1A-CCE0-4A48-ABED-180E73048950Q35950537-55943BB3-49A2-4CB9-91BF-3E0FDB6B63AFQ36323485-693BFD1E-B1F9-46EC-AC7A-481252F5DBEDQ37071276-B61B0316-15F4-4D5F-8829-0F575B95AAA3Q37121624-E91AFB80-90B3-4B62-9D32-049DCFAB2A7AQ37297026-1D332B0A-CF20-466A-B43F-AB4D6D75DADAQ37297837-F99D9DA9-EE9A-4B5B-869E-98173B042D13Q38054844-8DF08C01-529E-4EA4-83E5-98DEA7F77293Q38189504-B9DEF0C8-3662-4E3A-B936-00F09F8BBBEDQ39394235-CFEECF59-79EF-45AE-B42D-6D4A8B25A256Q39488378-82FC9997-F9EB-4BF4-BB82-2ED1FC47C642Q40092958-971CEC9B-1F90-4010-8A2F-82316BC0ADD3Q41090290-9AB3101B-FB27-419D-9A88-C2011DBF729CQ41543544-88492429-F0A4-4472-9799-44E71A396694Q41829964-7F7DCDB8-166B-400E-A16B-FCB6A0D6469AQ42742507-8161B779-5160-410B-BE0C-FFA012088F28Q43134488-BBE5518F-16CC-47FC-BBBA-E2DB436147F8Q43222979-7A6ADF4F-DE6A-4C10-83CC-EE22C8190301Q46020791-6244CF9C-947F-4FAD-A531-10CF3785044AQ46289111-F41E8189-2B21-4063-940C-E71606136E40Q47554176-31F9B45F-4702-4D81-A2B1-A6D7C6299750Q47558448-09B0B7C3-712F-4D20-85CA-AF485337C493Q60222274-22612E9D-09E4-401B-B9C7-1B6B4A2C12C5Q90922985-FA452180-2633-4D3E-9432-9AEB58A42B64Q91395480-2348EB3D-A1DF-4FC9-AD11-AD292D59E2AA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Piotr Ruchala
@ast
Piotr Ruchala
@en
Piotr Ruchala
@es
Piotr Ruchala
@nl
type
label
Piotr Ruchala
@ast
Piotr Ruchala
@en
Piotr Ruchala
@es
Piotr Ruchala
@nl
prefLabel
Piotr Ruchala
@ast
Piotr Ruchala
@en
Piotr Ruchala
@es
Piotr Ruchala
@nl
P106
P31
P496
0000-0002-5574-2779